|Articles|November 2, 2003
- Pharmaceutical Technology-11-02-2003
- Volume 27
- Issue 11
Clearing Regulatory Hurdles
Author(s)Christopher C. DeMerlis
The authors propose several models for independent evaluation of new excipients.
Advertisement
Articles in this issue
over 22 years ago
FDA Will Drive Changes for Contract Businessover 22 years ago
In the Spotlight--Decemberover 22 years ago
Novemember 2003over 22 years ago
FDA Seeks Risk-Based Inspection Programover 22 years ago
Routine Sample Size for a Retest Procedureover 22 years ago
November 2003over 22 years ago
Improving Protein Capture for Transgenic Drug ProcessingAdvertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Why Big Pharma Is Betting Billions on Protein Degraders for Cancer
2
GSK Acquires Nuvalent for $10.6 Billion in Lung Cancer Push
3
USP Reports Drug Discontinuations on the Rise
4
Enhancing Clinical Data Infrastructure for AI Research: A Strategic Guide for Pharma Professionals
5
